Subtype-specific modulation of estrogen receptor-coactivator interaction by phosphorylation

Area of Science:

• Endocrinology
• Molecular Biology
• Chemical Biology

Background:

• The estrogen receptor (ER) is a key target for endocrine-responsive breast cancer treatment.
• Understanding ER post-translational modifications (PTMs) is crucial for drug development, but their molecular impact remains unclear.
• Tyrosine phosphorylation is a significant PTM affecting ER function.

Purpose of the Study:

• To elucidate the molecular mechanisms of ER tyrosine phosphorylation.
• To investigate the role of specific tyrosine phosphorylation sites (Y537 in ERα and Y488 in ERβ) in ER function.
• To develop a novel molecular model for ER regulation.

Main Methods:

• Protein semisynthesis to create site-specifically tyrosine phosphorylated ER constructs.
• Biophysical techniques including Nuclear Magnetic Resonance (NMR).
• Molecular dynamics simulations.

Main Results:

• Phosphorylation of Y537 in ERα and Y488 in ERβ significantly affects Helix 12 dynamics.
• These phosphorylation events influence ligand and cofactor binding.
• Differential regulatory effects were observed between ERα and ERβ subtypes.

Conclusions:

• A novel molecular model for phosphorylation-induced, subtype-specific ER modulation is proposed.
• This mechanism offers an alternative to the traditional ligand-induced activation model.
• Findings provide new insights into ER regulation for breast cancer therapy.